Medicago is constructing a new influenza vaccine production facility in the Estimauville Innovation Area in Quebec City, Canada.
15 November 2018 projects
6 November 2018 News
The European Centre for Disease Prevention and Control (ECDC) has found in an analysis that multi-drug resistant superbugs result in 33,000 deaths every year across Europe.
17 August 2018 projects
Germany-based pharmaceutical company Boehringer Ingelheim’s veterinary research and development (R&D) centre is located within its research and development (R&D) site in Shanghai, China.
31 May 2018 projects
In April 2018, global animal health company Zoetis began constructing a new animal vaccine manufacturing and research facility in Suzhou, China.
22 March 2018 projects
The Biomedical Engineering and Advanced Manufacturing (BEAM) centre is located in McMaster Innovation Park in Hamilton, Ontario, Canada.
22 February 2018 Comment
GlobalData projects the total revenue from branded infectious diseases (ID) drugs and vaccines to surpass $75bn in 2017.
18 September 2017
Immunocore has secured up to $40m in investment from Bill & Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat infectious diseases, in particular...
19 June 2017
In recent years emerging markets are gaining precedence in the pharmaceutical industry.
27 February 2014 projects
The Public Health Agency of Canada (PHAC) opened a new infectious diseases research centre at 745 Logan Avenue in the Winnipeg city of Manitoba province, Canada, in February 2014.
7 January 2014
Japanese pharmaceutical firm Astellas Pharma has entered into a strategic partnership with ClearPath Development Company to form a portfolio of development companies focused on producing vaccines for infectious diseases.